3g8i

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 3: Line 3:
The entry 3g8i is ON HOLD
The entry 3g8i is ON HOLD
-
Authors: Benz, J., Bernardeau, A., Binggeli, A., Blum, D., Boehringer , M., Grether, U., Hilpert, H., Kuhn, B., Maerki, H.P., Meyer, M., Puentener, K., Raab, S., Ruf, A., Schlatter, D., Gsell, B., Stihle, M., Mohr, P.
+
Authors: Benardeau, A.
Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes
Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 14:45:01 2009''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 11 11:10:55 2009''

Revision as of 09:10, 11 March 2009

Unreleased structure

The entry 3g8i is ON HOLD

Authors: Benardeau, A.

Description: Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes

Page seeded by OCA on Wed Mar 11 11:10:55 2009

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/3g8i"
Personal tools